Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists

References

• 1. Reitamo JJ, Häyry P, Nykyri E, Saxén E. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 1982;77(6):665–673.
  MedlineGoogle Scholar
• 2. Papagelopoulos PJ, Mavrogenis AF, Mitsiokapa EA, Papaparaskeva KT, Galanis EC, Soucacos PN. Current trends in the management of extra-abdominal desmoid tumours. World J Surg Oncol 2006;4:21.
  MedlineGoogle Scholar
• 3. Nieuwenhuis MH, Casparie M, Mathus-Vliegen LM, Dekkers OM, Hogendoorn PC, Vasen HF. A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses. Int J Cancer 2011;129(1):256–261.
  MedlineGoogle Scholar
• 4. Robinson WA, McMillan C, Kendall A, Pearlman N. Desmoid tumors in pregnant and postpartum women. Cancers (Basel) 2012;4(1):184–192.
  MedlineGoogle Scholar
• 5. Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB. Intra-abdominal fibromatosis: a pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 1990;14(4):335–341.
  MedlineGoogle Scholar
• 6. Vandevenne JE, De Schepper AM, De Beuckeleer L, et al. New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions. Eur Radiol 1997;7(7):1013–1019.
  MedlineGoogle Scholar
• 7. Fisher C, Thway K. Aggressive fibromatosis. Pathology 2014;46(2):135–140.
  MedlineGoogle Scholar
• 8. Kasper B, Baumgarten C, Bonvalot S, et al. Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients’ and professionals’ expertise—a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative. Eur J Cancer 2015;51(2):127–136.
  MedlineGoogle Scholar
• 9. Le Guellec S, Soubeyran I, Rochaix P, et al. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol 2012;25(12):1551–1558.
  MedlineGoogle Scholar
• 10. Joglekar SB, Rose PS, Sim F, Okuno S, Petersen I. Current perspectives on desmoid tumors: the Mayo Clinic approach. Cancers (Basel) 2011;3(3):3143–3155.
  MedlineGoogle Scholar
• 11. Salas S, Dufresne A, Bui B, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol 2011;29(26):3553–3558.
  MedlineGoogle Scholar
• 12. Lou L, Teng J, Qi H, Ban Y. Sonographic appearances of desmoid tumors. J Ultrasound Med 2014;33(8):1519–1525.
  MedlineGoogle Scholar
• 13. Ebrahim L, Parry J, Taylor DB. Fibromatosis of the breast: a pictorial review of the imaging and histopathology findings. Clin Radiol 2014;69(10):1077–1083.
  MedlineGoogle Scholar
• 14. Bernathova M, Felfernig M, Rachbauer F, et al. Sonographic imaging of abdominal and extraabdominal desmoids. Ultraschall Med 2008;29(5):515–519.
  MedlineGoogle Scholar
• 15. Dinauer PA, Brixey CJ, Moncur JT, Fanburg-Smith JC, Murphey MD. Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults. RadioGraphics 2007;27(1):173–187.
  Google Scholar
• 16. Huang CC, Ko SF, Yeh MC, et al. Aggressive fibromatosis of the chest wall: sonographic appearance of the fascial tail and staghorn patterns. J Ultrasound Med 2009;28(3):393–396.
  MedlineGoogle Scholar
• 17. Shinagare AB, Ramaiya NH, Jagannathan JP, et al. A to Z of desmoid tumors. AJR Am J Roentgenol 2011;197(6):W1008–W1014.
  MedlineGoogle Scholar
• 18. Murphey MD, Ruble CM, Tyszko SM, Zbojniewicz AM, Potter BK, Miettinen M. From the archives of the AFIP: musculoskeletal fibromatoses: radiologic-pathologic correlation. RadioGraphics 2009;29(7):2143–2173.
  Google Scholar
• 19. Rhim JH, Kim JH, Moon KC, et al. Desmoid-type fibromatosis in the head and neck: CT and MR imaging characteristics. Neuroradiology 2013;55(3):351–359.
  MedlineGoogle Scholar
• 20. Sinha A, Hansmann A, Bhandari S, et al. Imaging assessment of desmoid tumours in familial adenomatous polyposis: is state-of-the-art 1.5 T MRI better than 64-MDCT? Br J Radiol 2012;85(1015):e254–e261.
  MedlineGoogle Scholar
• 21. Magid D, Fishman EK, Jones B, Hoover HC, Feinstein R, Siegelman SS. Desmoid tumors in Gardner syndrome: use of computed tomography. AJR Am J Roentgenol 1984;142(6):1141–1145.
  MedlineGoogle Scholar
• 22. McCarville MB, Hoffer FA, Adelman CS, Khoury JD, Li C, Skapek SX. MRI and biologic behavior of desmoid tumors in children. AJR Am J Roentgenol 2007;189(3):633–640.
  MedlineGoogle Scholar
• 23. Lee JC, Thomas JM, Phillips S, Fisher C, Moskovic E. Aggressive fibromatosis: MRI features with pathologic correlation. AJR Am J Roentgenol 2006;186(1):247–254.
  MedlineGoogle Scholar
• 24. Guglielmi G, Cifaratti A, Scalzo G, Magarelli N. Imaging of superficial and deep fibromatosis. Radiol Med (Torino) 2009;114(8):1292–1307.
  MedlineGoogle Scholar
• 25. Robbin MR, Murphey MD, Temple HT, Kransdorf MJ, Choi JJ. Imaging of musculoskeletal fibromatosis. RadioGraphics 2001;21(3):585–600.
  Google Scholar
• 26. Basu S, Nair N, Banavali S. Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management. Br J Radiol 2007;80(957):750–756.
  MedlineGoogle Scholar
• 27. Chew NS, Vanhoenacker FM. Aggressive fibromatosis: is PET-CT useful in lesion characterization? JBR-BTR 2013;96(5):301–303.
  MedlineGoogle Scholar
• 28. Souza FF, Fennessy FM, Yang Q, van den Abbeele AD. Case report: PET/CT appearance of desmoid tumour of the chest wall. Br J Radiol 2010;83(986):e39–e42.
  MedlineGoogle Scholar
• 29. Bertagnolli MM, Morgan JA, Fletcher CD, et al. Multimodality treatment of mesenteric desmoid tumours. Eur J Cancer 2008;44(16):2404–2410.
  MedlineGoogle Scholar
• 30. Zeng WG, Zhou ZX, Liang JW, et al. Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution. Tumour Biol 2014;35(8):7513–7521.
  MedlineGoogle Scholar
• 31. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999;17(1):158–167.
  MedlineGoogle Scholar
• 32. Abbas AE, Deschamps C, Cassivi SD, et al. Chest-wall desmoid tumors: results of surgical intervention. Ann Thorac Surg 2004;78(4):1219–1223; discussion 1219–1223.
  MedlineGoogle Scholar
• 33. Huang K, Wang CM, Chen JG, et al. Prognostic factors influencing event-free survival and treatments in desmoid-type fibromatosis: analysis from a large institution. Am J Surg 2014;207(6):847–854.
  MedlineGoogle Scholar
• 34. National Comprehensive Cancer Network. Soft tissue sarcoma, NCCN clinical practice guidelines in oncology (NCCN guidelines), version 1.2015. Fort Washington, Pa: National Comprehensive Cancer Network, 2015.
  Google Scholar
• 35. Mullen JT, Delaney TF, Kobayashi WK, et al. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol 2012;19(13):4028–4035.
  MedlineGoogle Scholar
• 36. Oweis Y, Lucas DR, Brandon CJ, Girish G, Jacobson JA, Fessell DP. Extra-abdominal desmoid tumor with osseous involvement. Skeletal Radiol 2012;41(4):483–487.
  MedlineGoogle Scholar
• 37. Togral G, Yildizgoren MT, Arikan M, Gungor S. Destructive invasion of the clavicle by desmoid tumor: a case report. Pan Afr Med J 2014;19:383.
  MedlineGoogle Scholar
• 38. Lev D, Kotilingam D, Wei C, et al. Optimizing treatment of desmoid tumors. J Clin Oncol 2007;25(13):1785–1791.
  MedlineGoogle Scholar
• 39. Fiore M, Rimareix F, Mariani L, et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol 2009;16(9):2587–2593.
  MedlineGoogle Scholar
• 40. Wang YF, Guo W, Sun KK, et al. Postoperative recurrence of desmoid tumors: clinical and pathological perspectives. World J Surg Oncol 2015;13:26.
  MedlineGoogle Scholar
• 41. Sørensen A, Keller J, Nielsen OS, Jensen OM. Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1–27 years. Acta Orthop Scand 2002;73(2):213–219.
  MedlineGoogle Scholar
• 42. Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 2003;21(7):1390–1397.
  MedlineGoogle Scholar
• 43. He XD, Zhang YB, Wang L, et al. Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: analysis of 114 patients at a single institution. Eur J Surg Oncol 2015;41(8):1013–1019.
  MedlineGoogle Scholar
• 44. Gansar GF, Markowitz IP, Cerise EJ. Thirty years of experience with desmoid tumors at Charity Hospital. Am Surg 1987;53(6):318–319.
  MedlineGoogle Scholar
• 45. Winant AJ, Vora A, Ginter PS, Levine MS, Brylka DA. More than just metastases: a practical approach to solid mesenteric masses. Abdom Imaging 2014;39(3):605–621.
  MedlineGoogle Scholar
• 46. Shapeero LG, De Visschere PJ, Verstraete KL, et al. Post-treatment complications of soft tissue tumours. Eur J Radiol 2009;69(2):209–221.
  MedlineGoogle Scholar
• 47. Bonvalot S. Sporadic abdominal wall desmoid: is it time to change our first-line approach? Ann Surg Oncol 2014;21(7):2117–2118.
  MedlineGoogle Scholar
• 48. Pignatti G, Barbanti-Bròdano G, Ferrari D, et al. Extraabdominal desmoid tumor: a study of 83 cases. Clin Orthop Relat Res 2000(375):207–213.
  MedlineGoogle Scholar
• 49. Phillips SR, A’Hern R, Thomas JM. Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. Br J Surg 2004;91(12):1624–1629.
  MedlineGoogle Scholar
• 50. Briand S, Barbier O, Biau D, et al. Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors. J Bone Joint Surg Am 2014;96(8):631–638.
  MedlineGoogle Scholar
• 51. Bonvalot S, Desai A, Coppola S, et al. The treatment of desmoid tumors: a stepwise clinical approach. Ann Oncol 2012;23(suppl 10):x158–x166.
  MedlineGoogle Scholar
• 52. Healy JC, Reznek RH, Clark SK, Phillips RK, Armstrong P. MR appearances of desmoid tumors in familial adenomatous polyposis. AJR Am J Roentgenol 1997;169(2):465–472.
  MedlineGoogle Scholar
• 53. Castellazzi G, Vanel D, Le Cesne A, et al. Can the MRI signal of aggressive fibromatosis be used to predict its behavior? Eur J Radiol 2009;69(2):222–229.
  MedlineGoogle Scholar
• 54. Tsukada K, Church JM, Jagelman DG, et al. Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 1992;35(1):29–33.
  MedlineGoogle Scholar
• 55. Lim CL, Walker MJ, Mehta RR, Das Gupta TK. Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 1986;22(5):583–587.
  MedlineGoogle Scholar
• 56. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 2004;100(3):612–620.
  MedlineGoogle Scholar
• 57. Constantinidou A, Jones RL, Scurr M, Al-Muderis O, Judson I. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer 2009;45(17):2930–2934.
  MedlineGoogle Scholar
• 58. de Camargo VP, Keohan ML, D’Adamo DR, et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer 2010;116(9):2258–2265.
  MedlineGoogle Scholar
• 59. Gounder MM, Lefkowitz RA, Keohan ML, et al. Activity of sorafenib against desmoid tumor/deep fibromatosis. Clin Cancer Res 2011;17(12):4082–4090.
  MedlineGoogle Scholar
• 60. Kriz J, Eich HT, Haverkamp U, et al. Radiotherapy is effective for desmoid tumors (aggressive fibromatosis): long-term results of a German multicenter study. Oncol Res Treat 2014;37(5):255–260.
  MedlineGoogle Scholar
• 61. Nuyttens JJ, Rust PF, Thomas CR Jr, Turrisi AT 3rd. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer 2000;88(7):1517–1523.
  MedlineGoogle Scholar
• 62. Husain Z, Benevenia J, Uglialoro AD, et al. An evaluation of brachytherapy and external beam radiation used with wide-margin surgical resection in the treatment of extra-abdominal desmoid tumors. Am J Orthop 2011;40(5):E78–E82.
  MedlineGoogle Scholar
• 63. Rüdiger HA, Ngan SY, Ng M, Powell GJ, Choong PF. Radiation therapy in the treatment of desmoid tumours reduces surgical indications. Eur J Surg Oncol 2010;36(1):84–88.
  MedlineGoogle Scholar
• 64. Keus RB, Nout RA, Blay JY, et al. Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis–an EORTC STBSG and ROG study (EORTC 62991-22998). Ann Oncol 2013;24(10):2672–2676.
  MedlineGoogle Scholar